Stocks · News reference
BWMN gained 55.1%, HZO rose 45.8%, ABCL gained 35.6%, SLN rose 34.3%, ACHR gained 19.5%, NESR gained 16.4%, AQST gained 15.4%, STDN rose 13.7%.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
AbCellera (NASDAQ:ABCL) today announced an upcoming oral presentation of Phase 2 data on ABCL635 at the International Menopause Society (IMS) 20th World Congress on Menopause, to be held September 30 to October 3, 2026
AbCellera Biologics stock gains as investors react to Jazz Pharmaceuticals’ FDA approval and the companies’ antibody partnership.
Nasdaq: NYAX rose 13.9% on Tuesday after announcing acquisition of IPS Group Inc. for $350 million. Other big gainers include CAPR, RZLV, CRML, and MAIR.
Filed: 2026-08-13 AccNo: 0001193125-26-349353 Size: 616 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Archer Aviation stock has declined 62% from its October peak of $14.62 to $5.61, despite business progress in flight testing and FAA certification. The stock's recovery depends on three milestones: FAA type certificate approval, first fare revenue, and conversion of United Airlines' conditional purchase order for up to 200 aircraft. However, reaching the old high now requires a larger company valuation due to share dilution from stock-based compensation and the Boeing acquisition.
Archer Aviation and Joby Aviation, the two primary eVTOL companies competing for FAA certification, have similar balance sheets with nearly identical net cash positions of ~$1.5 billion each. However, Archer emerges as the winner due to higher shareholders' equity per share ($2.47 vs $1.82), despite Joby's larger cash hoard and market cap. Both companies have announced major acquisitions that could significantly impact their financial positions.